|
1
|
David S and Brunkhorst FM: Sepsis-3: What
has been confirmed in therapy? Internist (Berl). 58:1264–1271.
2017.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
2
|
Doganyigit Z, Eroglu E and Akyuz E:
Inflammatory mediators of cytokines and chemokines in sepsis: From
bench to bedside. Hum Exp Toxicol.
41(9603271221078871)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang M, Cai S and Su J: The pathogenesis
of sepsis and potential therapeutic targets. Int J Mol Sci.
20(5376)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gentile LF, Cuenca AG, Vanzant EL, Efron
PA, McKinley B, Moore F and Moldawer LL: Is there value in plasma
cytokine measurements in patients with severe trauma and sepsis?
Methods. 61:3–9. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rimmelé T, Payen D, Cantaluppi V, Marshall
J, Gomez H, Gomez A, Murray P and Kellum JA: ADQI XIV Workgroup.
Immune cell phenotype and function in sepsis. Shock. 45:282–291.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang JF, Li JB, Zhao YJ, Yi WJ, Bian JJ,
Wan XJ, Zhu KM and Deng XM: Up-regulation of programmed cell death
1 ligand 1 on neutrophils may be involved in sepsis-induced
immunosuppression: An animal study and a prospective case-control
study. Anesthesiology. 122:852–863. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Taneja R, Parodo J, Jia SH, Kapus A,
Rotstein OD and Marshall JC: Delayed neutrophil apoptosis in sepsis
is associated with maintenance of mitochondrial transmembrane
potential and reduced caspase-9 activity. Crit Care Med.
32:1460–1469. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hoesel LM, Neff TA, Neff SB, Younger JG,
Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV and Ward PA:
Harmful and protective roles of neutrophils in sepsis. Shock.
24:40–47. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pool R, Gomez H and Kellum JA: Mechanisms
of organ dysfunction in sepsis. Crit Care Clin. 34:63–80.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Vaki I, Kranidioti H, Karagianni V,
Spyridaki A, Kotsaki A, Routsi C and Giamarellos-Bourboulis EJ: An
early circulating factor in severe sepsis modulates apoptosis of
monocytes and lymphocytes. J Leukoc Biol. 89:343–349.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Venet F, Tissot S, Debard AL, Faudot C,
Crampé C, Pachot A, Ayala A and Monneret G: Decreased monocyte
human leukocyte antigen-DR expression after severe burn injury:
Correlation with severity and secondary septic shock. Crit Care
Med. 35:1910–1917. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Joshi I, Carney WP and Rock EP: Utility of
monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis
immunoparalysis. Front Immunol. 14(1130214)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hotchkiss RS, Monneret G and Payen D:
Immunosuppression in sepsis: A novel understanding of the disorder
and a new therapeutic approach. Lancet Infect Dis. 13:260–268.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Holub M, Klucková Z, Helcl M, Príhodov J,
Rokyta R and Beran O: Lymphocyte subset numbers depend on the
bacterial origin of sepsis. Clin Microbiol Infect. 9:202–211.
2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu H, Liu G and Tian Z: Changes in blood
lymphocytes in sepsis patients. Zhonghua Wei Zhong Bing Ji Jiu Yi
Xue. 26:148–152. 2014.PubMed/NCBI(In Chinese).
|
|
16
|
Zahorec R: Ratio of neutrophil to
lymphocyte counts-rapid and simple parameter of systemic
inflammation and stress in critically ill. Bratisl Lek Listy.
102:5–14. 2001.PubMed/NCBI(In English, Slovak).
|
|
17
|
Huang Z, Fu Z, Huang W and Huang K:
Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A
meta-analysis. Am J Emerg Med. 38:641–647. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kriplani A, Pandit S, Chawla A, de la
Rosette JJMCH, Laguna P, Jayadeva Reddy S and Somani BK:
Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR)
and lymphocyte-monocyte ratio (LMR) in predicting systemic
inflammatory response syndrome (SIRS) and sepsis after percutaneous
nephrolithotomy (PNL). Urolithiasis. 50:341–348. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang G, Mivefroshan A, Yaghoobpoor S,
Khanzadeh S, Siri G, Rahmani F and Aleseidi S: Prognostic value of
platelet to lymphocyte ratio in sepsis: A systematic review and
meta-analysis. Biomed Res Int. 2022(9056363)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang S, Luan X, Zhang W and Jin Z:
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio as
predictive biomarkers for early-onset neonatal sepsis. J Coll
Physicians Surg Pak. 30:821–824. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fois AG, Paliogiannis P, Scano V, Cau S,
Babudieri S, Perra R, Ruzzittu G, Zinellu E, Pirina P, Carru C, et
al: The systemic inflammation index on admission predicts
in-hospital mortality in COVID-19 patients. Molecules.
25(5725)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Singer M, Deutschman CS, Seymour CW,
Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche
JD, Coopersmith CM, et al: The third international consensus
definitions for sepsis and septic shock (sepsis-3). JAMA.
315:801–810. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Măruşteri M and Bacârea V: Comparing
groups for statistical differences: How to choose the right
statistical test? Biochem Med. 20:15–32. 2010.
|
|
24
|
Djordjevic D, Rondovic G, Surbatovic M,
Stanojevic I, Udovicic I, Andjelic T, Zeba S, Milosavljevic S,
Stankovic N, Abazovic D, et al: Neutrophil-to-lymphocyte ratio,
monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and
mean platelet volume-to-platelet count ratio as biomarkers in
critically ill and injured patients: Which ratio to choose to
predict outcome and nature of bacteremia? Mediators Inflamm.
2018(3758068)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kingren MS, Starr ME and Saito H:
Divergent sepsis pathophysiology in older adults. Antioxid Redox
Signal. 35:1358–1375. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bacârea A, Bacârea VC, Buicu F, Crăciun C,
Kosovski B, Guiné R and Tarcea M: Emotional eating sustainability
in Romania-A questionnaire-based study. Sustainability.
15(2895)2023.
|
|
27
|
Bacârea A, Tarcea M, Boţianu PVH, Ruţă F
and Bacârea V: Age cut-off for type 2 diabetes mellitus screening
amongst young adults from Mures District, Romania-A pilot study.
Obes Res Clin Pract. 9:527–530. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Schetz M, De Jong A, Deane AM, Druml W,
Hemelaar P, Pelosi P, Pickkers P, Reintam-Blaser A, Roberts J, Sakr
Y and Jaber S: Obesity in the critically ill: A narrative review.
Intensive Care Med. 45:757–769. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kalani C, Venigalla T, Bailey J, Udeani G
and Surani S: Sepsis patients in critical care units with obesity:
Is obesity protective? Cureus. 12(e6929)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bauer M, Gerlach H, Vogelmann T, Preissing
F, Stiefel J and Adam D: Mortality in sepsis and septic shock in
Europe, North America and Australia between 2009 and 2019-results
from a systematic review and meta-analysis. Crit Care.
24(239)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bauer M, Groesdonk HV, Preissing F,
Dickmann P, Vogelmann T and Gerlach H: Mortality in sepsis and
septic shock in Germany. Results of a systematic review and
meta-analysis. Anaesthesist. 70:673–680. 2021.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
32
|
Fattahi F and Ward PA: Understanding
immunosuppression after sepsis. Immunity. 47:3–5. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hotchkiss RS, Monneret G and Payen D:
Sepsis-induced immunosuppression: From cellular dysfunctions to
immunotherapy. Nat Rev Immunol. 13:862–874. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Riché F, Gayat E, Barthélémy R, Le Dorze
M, Matéo J and Payen D: Reversal of neutrophil-to-lymphocyte count
ratio in early versus late death from septic shock. Crit Care.
19(439)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Leliefeld PH, Wessels CM, Leenen LP,
Koenderman L and Pillay J: The role of neutrophils in immune
dysfunction during severe inflammation. Crit Care.
20(73)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Boomer JS, Green JM and Hotchkiss RS: The
changing immune system in sepsis: Is individualized
immuno-modulatory therapy the answer? Virulence. 5:45–56.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Martin MD, Badovinac VP and Griffith TS:
CD4 T cell responses and the sepsis-induced immunoparalysis state.
Front Immunol. 11(1364)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Danahy DB, Strother RK, Badovinac VP and
Griffith TS: Clinical and experimental sepsis impairs CD8
T-cell-mediated immunity. Crit Rev Immunol. 36:57–74.
2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen R, Qin S, Zhu H, Chang G, Li M, Lu H,
Shen M, Gao Q and Lin X: Dynamic monitoring of circulating
CD8+ T and NK cell function in patients with septic
shock. Immunol Lett. 243:61–68. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Peng Y, Wang X, Yin S and Wang M: A new
indicator: The diagnostic value of CD8+T/B lymphocyte ratio in
sepsis progression. Int J Immunopathol Pharmacol.
36(3946320221123164)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ma C, Liu H, Yang S, Li H, Liao X and Kang
Y: The emerging roles and therapeutic potential of B cells in
sepsis. Front Pharmacol. 13(1034667)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gustave CA, Gossez M, Demaret J, Rimmelé
T, Lepape A, Malcus C, Poitevin-Later F, Jallades L, Textoris J,
Monneret G and Venet F: Septic shock shapes B cell response toward
an exhausted-like/immunoregulatory profile in patients. J Immunol.
200:2418–2425. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen X and Ye J and Ye J: Analysis of
peripheral blood lymphocyte subsets and prognosis in patients with
septic shock. Microbiol Immunol. 55:736–742. 2011.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tian T, Wei B and Wang J: Study of
C-reactive protein, procalcitonin, and immunocyte ratios in 194
patients with sepsis. BMC Emerg Med. 21(81)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Russell CD, Parajuli A, Gale HJ, Bulteel
NS, Schuetz P, de Jager CPC, Loonen AJM, Merekoulias GI and Baillie
JK: The utility of peripheral blood leucocyte ratios as biomarkers
in infectious diseases: A systematic review and meta-analysis. J
Infect. 78:339–348. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ma K, Zhang Y, Hao J, Zhao J, Qi Y and Liu
C: Correlation analysis of systemic immune inflammatory index,
serum IL-35 and HMGB-1 with the severity and prognosis of sepsis.
Pak J Med Sci. 39:497–501. 2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Pierrakos C, Velissaris D, Bisdorff M,
Marshall JC and Vincent JL: Biomarkers of sepsis: Time for a
reappraisal. Crit Care. 24(287)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Faix JD: Biomarkers of sepsis. Crit Rev
Clin Lab Sci. 50:23–36. 2013.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ryu JA, Yang JH, Lee D, Park CM, Suh GY,
Jeon K, Cho J, Baek SY, Carriere KC and Chung CR: Clinical
usefulness of procalcitonin and c-reactive protein as outcome
predictors in critically ill patients with severe sepsis and septic
shock. PLoS One. 10(e0138150)2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Knaak C, Nyvlt P, Schuster FS, Spies C,
Heeren P, Schenk T, Balzer F, La Rosée P, Janka G, Brunkhorst FM,
et al: Hemophagocytic lymphohistiocytosis in critically ill
patients: Diagnostic reliability of HLH-2004 criteria and HScore.
Crit Care. 24(244)2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Fang YP, Zhang HJ, Guo Z, Ren CH, Zhang
YF, Liu Q, Wang Z and Zhang X: Effect of serum ferritin on the
prognosis of patients with sepsis: Data from the MIMIC-IV database.
Emerg Med Int. 2022(2104755)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Karakike E and Giamarellos-Bourboulis EJ:
Macrophage activation-like syndrome: A distinct entity leading to
early death in sepsis. Front Immunol. 10(55)2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Schupp T, Weidner K, Rusnak J, Jawhar S,
Forner J, Dulatahu F, Dudda J, Brück LM, Hoffmann U, Bertsch T, et
al: C-reactive protein and procalcitonin during course of sepsis
and septic shock. Ir J Med Sci. 193:457–468. 2024.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Hillas G, Vassilakopoulos T, Plantza P,
Rasidakis A and Bakakos P: C-reactive protein and procalcitonin as
predictors of survival and septic shock in ventilator-associated
pneumonia. Eur Respir J. 35:805–811. 2010.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Stoichitoiu LE, Pinte L, Ceasovschih A,
Cernat RC, Vlad ND, Padureanu V, Sorodoc L, Hristea A, Purcarea A,
Badea C and Baicus C: In-hospital antibiotic use for COVID-19:
Facts and rationales assessed through a mixed-methods study. J Clin
Med. 11(3194)2022.PubMed/NCBI View Article : Google Scholar
|
